6505--Mesalamine 1200mg Tablet

The Department of Veterans Affairs National Acquisition Center is soliciting competitive bids for Mesalamine 1200mg tablets (enteric coated, delayed release) on a requirements contract basis, with proposals due June 18, 2026 at 2:30 PM Central Time. The due date was extended from June 11 by amendment issued June 2. The solicitation is unrestricted, not set-aside for small business.

The estimated annual requirement is 107,364 bottles in unit-of-use containers of 120 tablets. One award will be made for a base year plus four one-year option periods. The contract will be distributed through Government Prime Vendor programs serving the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, and Captain James A. Lovell Federal Health Care Center, with implementation within 60 days of award.

Offerors must submit pricing for the base year and each optional year with prices not exceeding two decimal places, and all prices must include a 0.5% Cost Recovery Fee. Offerors must provide a unique 11-digit NDC number specific to their company. Non-manufacturers must submit a Letter of Commitment from the manufacturer guaranteeing supply. Contractors must establish business-to-business agreements with designated PPVs (McKesson for VA; McKesson, Cencora, Cardinal Health, and DMS Pharmaceutical Group for DoD), comply with FDA current Good Manufacturing Practice standards and Drug Supply Chain Security Act requirements, register the product with FDA and drug databases, meet bar coding standards, and submit quarterly sales reports with Cost Recovery Fee payments. Failure to establish or maintain PPV agreements or meet 15 calendar-day backorder delivery requirements may result in contract termination for cause. NAICS code is 325412, Pharmaceutical Preparation Manufacturing. PSC code is 6505, Drugs and Biologicals.